 Clinical Trials as Topic
"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
| Descriptor ID |
D002986
|
| MeSH Number(s) |
E05.318.760.535 E05.337.250 N05.715.360.775.235 N06.850.520.450.535
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 6 | 6 | | 1981 | 1 | 4 | 5 | | 1982 | 0 | 9 | 9 | | 1983 | 0 | 9 | 9 | | 1984 | 0 | 9 | 9 | | 1985 | 0 | 11 | 11 | | 1986 | 1 | 8 | 9 | | 1987 | 0 | 15 | 15 | | 1988 | 0 | 14 | 14 | | 1989 | 0 | 11 | 11 | | 1990 | 0 | 6 | 6 | | 1991 | 0 | 2 | 2 | | 1992 | 4 | 4 | 8 | | 1993 | 1 | 3 | 4 | | 1994 | 2 | 4 | 6 | | 1995 | 4 | 10 | 14 | | 1996 | 3 | 9 | 12 | | 1997 | 1 | 13 | 14 | | 1998 | 0 | 7 | 7 | | 1999 | 4 | 8 | 12 | | 2000 | 4 | 21 | 25 | | 2001 | 6 | 14 | 20 | | 2002 | 5 | 24 | 29 | | 2003 | 8 | 22 | 30 | | 2004 | 10 | 45 | 55 | | 2005 | 5 | 34 | 39 | | 2006 | 13 | 46 | 59 | | 2007 | 7 | 31 | 38 | | 2008 | 9 | 37 | 46 | | 2009 | 12 | 43 | 55 | | 2010 | 10 | 34 | 44 | | 2011 | 18 | 29 | 47 | | 2012 | 17 | 29 | 46 | | 2013 | 14 | 25 | 39 | | 2014 | 10 | 23 | 33 | | 2015 | 13 | 28 | 41 | | 2016 | 11 | 25 | 36 | | 2017 | 14 | 16 | 30 | | 2018 | 8 | 32 | 40 | | 2019 | 17 | 12 | 29 | | 2020 | 11 | 26 | 37 | | 2021 | 13 | 15 | 28 | | 2022 | 2 | 6 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
Hanzel J, Jairath V, De Cruz P, Guizzetti L, Shackelton LM, Bossuyt P, Duijvestein M, Dulai PS, Grossmann J, Hirten RP, Khanna R, Panes J, Peyrin-Biroulet L, Regueiro M, Rubin DT, Singh S, Stidham RW, Sandborn WJ, Feagan BG, D'Haens GR, Ma C. Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease. Inflamm Bowel Dis. 2022 09 01; 28(9):1321-1331.
-
Muffly L, Yin J, Jacobson S, Wall A, Quiroz E, Advani AS, Luger SM, Tallman MS, Litzow MR, Foster MC, Erba HP, Appelbaum FR, Larson RA, Keegan THM, Stock W. Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia. Blood Adv. 2022 07 26; 6(14):4085-4092.
-
Howard FM, Pearson AT, Nanda R. Clinical trials of immunotherapy in triple-negative breast cancer. Breast Cancer Res Treat. 2022 Aug; 195(1):1-15.
-
Stensland KD, Damschroder LJ, Sales AE, Schott AF, Skolarus TA. Envisioning clinical trials as complex interventions. Cancer. 2022 09 01; 128(17):3145-3151.
-
Sharrock MF, Mould WA, Hildreth M, Ryu EP, Walborn N, Awad IA, Hanley DF, Muschelli J. Bayesian deep learning outperforms clinical trial estimators of intracerebral and intraventricular hemorrhage volume. J Neuroimaging. 2022 09; 32(5):968-976.
-
Greenland P, Polonsky TS. 40 Years of Research on Coronary Artery Calcium and Still No Convincing Clinical Trials? JACC Cardiovasc Imaging. 2022 05; 15(5):856-858.
-
Guillo L, Abreu M, Panaccione R, Sandborn WJ, Azevedo VF, Gensler L, Moghaddam B, Ahuja V, Ali SA, Allez M, Ananthakrishnan AN, Bhattacharya A, Dubinsky M, Griffiths A, Hart A, Korelitz B, Kotze PG, Koutroubakis IE, Lakatos PL, Lindsay JO, Magro F, Mantzaris GJ, Ng SC, O'Morain C, Panés J, Parigi T, Ran Z, Rogler G, Rubin DT, Sachar DB, Siegmund B, Steinwurz F, Tysk C, Vavricka S, Verstraete SG, Brezin AP, Haemel AK, Dignass A, Sands BE, Danese S, Peyrin-Biroulet L. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. Lancet Gastroenterol Hepatol. 2022 03; 7(3):254-261.
-
Stavas J, Gerber D, Coca SG, Silva AL, Johns A, Jain D, Bertram T, Díaz-González de Ferris M, Bakris G. Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design. Am J Nephrol. 2022; 53(1):50-58.
-
Gordon KB, Lebwohl M, Papp KA, Bachelez H, Wu JJ, Langley RG, Blauvelt A, Kaplan B, Shah M, Zhao Y, Sinvhal R, Reich K. Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis. Br J Dermatol. 2022 03; 186(3):466-475.
-
Herman AL, Sheth KN, Williams OA, Johnston KC, Prabhakaran S, de Havenon A. Self-Reported Race as a Social Determinant of Stroke Risk in Observational Versus Clinical Trial Datasets. J Stroke Cerebrovasc Dis. 2022 Feb; 31(2):106219.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|